Despite significant treatment advancements in the management of multiple myeloma over the last 20 years, racial disparities in health care access and survival continue to exist. READ MORE

News

Current value frameworks issued by leading medical societies may not be easily generalizable to the treatment of hematologic malignancies.

READ MORE

Patients with acute myeloid leukemia (AML) whose cells carry TP53 mutations may survive longer if they are treated with decitabine.

READ MORE